STOCK TITAN

MariMed Announces Fourth Quarter 2022 Earnings Date

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

MariMed Inc. (CSE: MRMD, OTCQX: MRMD), a multi-state cannabis operator, announced it will release its Q4 2022 financial results on March 1, 2023, after market close. Following this, management will host a conference call on March 2, 2023, at 8:00 a.m. EST to discuss the results. Investors can access a webcast of the earnings call via MariMed's Investor Relations website. The company focuses on high-quality cannabis products and operates state-licensed facilities, aiming to enhance lives through its innovative offerings. For more information, visit www.marimedinc.com.

Positive
  • None.
Negative
  • None.

NORWOOD, Mass., Feb. 01, 2023 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”), (CSE: MRMD), (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced it will report its fourth quarter 2022 financial results on March 1, 2023 after the markets close. Management will host a conference call on March 2, 2023 at 8:00 a.m. EST to discuss financial results.

A webcast will be available and can be accessed via MariMed’s Investor Relations website at MariMed Q422 Earnings Webcast. To listen to the live call, please visit the website at least 15 minutes prior to the call to register, download and install any necessary audio software. A playback of the call will be archived on MariMed’s website for approximately 30 days.

About MariMed
MariMed Inc., a multi-state cannabis operator, is dedicated to improving lives every day through its high-quality products, its actions, and its values. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. Proprietary formulations created by the Company’s technicians are embedded in its top-selling and award-winning products and brands, including Betty's Eddies, Nature’s Heritage, InHouse, Bubby’s Baked, K Fusion, Kalm Fusion, and Vibations: High + Energy. For additional information, visit www.marimedinc.com.

Investor Relations Contact:
Steve West
Vice President, Investor Relations
Email: ir@marimedinc.com
Phone: (781) 277-0007

Company Contact:
Howard Schacter
Chief Communications Officer
Email: hschacter@marimedinc.com
Phone: (781) 277-0007


FAQ

When will MariMed report its Q4 2022 financial results?

MariMed will report its Q4 2022 financial results on March 1, 2023.

What time is the MariMed conference call for financial results?

The conference call will take place on March 2, 2023, at 8:00 a.m. EST.

Where can I listen to the MariMed earnings call?

The earnings call can be accessed through MariMed's Investor Relations website.

What is the ticker symbol for MariMed?

MariMed's ticker symbols are MRMD for both CSE and OTCQX.

MARIMED INC

OTC:MRMD

MRMD Rankings

MRMD Latest News

MRMD Stock Data

64.32M
342.15M
14.01%
0.79%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Norwood